Alyeska Investment Group
TARA icon

Alyeska Investment Group’s Protara Therapeutics TARA Stock Holding History

Alyeska Investment Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Hold
350,000
– – 0.01% 550
2025
Q4 		$1.87M Buy
+350,000
New +$1.95M 0.01% 524
2021
Q2 		– Sell
-109,405
Closed -$1.72M – 831
2021
Q1 		$1.72M Buy
109,405
+35,000
+47% +$649K 0.02% 495
2020
Q4 		$1.8M Sell
74,405
-125,595
-63% -$2.71M 0.03% 381
2020
Q3 		$3.37M Buy
+200,000
New +$4.64M 0.06% 299
2015
Q1 		– Sell
-1,157
Closed -$481K – 584
2014
Q4 		$481K Buy
+1,157
New +$467K 0.01% 444

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $1.89B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return